226 related articles for article (PubMed ID: 17618877)
1. Port-A-Cath insertions in acute leukemia: does thrombocytopenia affect morbidity?
Loh AH; Chui CH
J Pediatr Surg; 2007 Jul; 42(7):1180-4. PubMed ID: 17618877
[TBL] [Abstract][Full Text] [Related]
2. Port-A-Cath insertions in acute leukaemia and childhood malignancies.
Loh AH; Chui CH
Asian J Surg; 2007 Jul; 30(3):193-9. PubMed ID: 17638639
[TBL] [Abstract][Full Text] [Related]
3. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia.
Zeidler K; Arn K; Senn O; Schanz U; Stussi G
Transfusion; 2011 Nov; 51(11):2269-76. PubMed ID: 21517892
[TBL] [Abstract][Full Text] [Related]
4. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.
Ng F; Mastoroudes H; Paul E; Davies N; Tibballs J; Hochhauser D; Mayer A; Begent R; Meyer T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):551-6. PubMed ID: 17517500
[TBL] [Abstract][Full Text] [Related]
5. Port-A-Cath infections in children with cancer.
Hengartner H; Berger C; Nadal D; Niggli FK; Grotzer MA
Eur J Cancer; 2004 Nov; 40(16):2452-8. PubMed ID: 15519519
[TBL] [Abstract][Full Text] [Related]
6. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
[TBL] [Abstract][Full Text] [Related]
7. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
[TBL] [Abstract][Full Text] [Related]
8. Central venous catheterization in pediatric patients affected by hematological malignancies.
Cogliati AA; Dell'Utri D; Picardi A; Testi AM; Micozzi A; Pasotti E; Rosa G
Haematologica; 1995; 80(5):448-50. PubMed ID: 8566889
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneously implanted central venous access device infection in pediatric patients with cancer.
Hung MC; Chen CJ; Wu KG; Hung GY; Lin YJ; Tang RB
J Microbiol Immunol Infect; 2009 Apr; 42(2):166-71. PubMed ID: 19597650
[TBL] [Abstract][Full Text] [Related]
10. Prolonged venous access in cancer patients.
Guenier C; Ferreira J; Pector JC
Eur J Surg Oncol; 1989 Dec; 15(6):553-5. PubMed ID: 2599125
[TBL] [Abstract][Full Text] [Related]
11. Complications associated with an implantable vascular access device.
Dillon PA; Foglia RP
J Pediatr Surg; 2006 Sep; 41(9):1582-7. PubMed ID: 16952595
[TBL] [Abstract][Full Text] [Related]
12. Severe neutropenia at time of port insertion is not a risk factor for catheter-associated infections in children with acute lymphoblastic leukemia.
Junqueira BL; Connolly B; Abla O; Tomlinson G; Amaral JG
Cancer; 2010 Sep; 116(18):4368-75. PubMed ID: 20564151
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness and indications for Port-a-Cath in children with acute leukemia].
Parri FJ; Rovira J; Sancho MA; Julia V; Albert A; Morales L
Cir Pediatr; 1989 Apr; 2(2):61-3. PubMed ID: 2485670
[TBL] [Abstract][Full Text] [Related]
14. [Experiences with a modified implantation technique of Port-A-Cath systems as continuous venous access in infants and children].
Erhard J; Lange R; Kremens B; Krause U; Eigler FW
Med Klin (Munich); 1991 Oct; 86(10):512-4. PubMed ID: 1758373
[TBL] [Abstract][Full Text] [Related]
15. [Complications of the use of implantable reservoirs of central venous access++ in pediatrics: causes and treatment].
Pérez Martínez A; Martínez Ibáñez V; Ezzedine M
Cir Pediatr; 1993 Apr; 6(2):59-62. PubMed ID: 8357723
[TBL] [Abstract][Full Text] [Related]
16. The safety of central line placement prior to treatment of pediatric acute lymphoblastic leukemia.
Carr E; Jayabose S; Stringel G; Slim M; Ozkaynak MF; Tugal O; Sandoval C
Pediatr Blood Cancer; 2006 Dec; 47(7):886-8. PubMed ID: 16200633
[TBL] [Abstract][Full Text] [Related]
17. Retrospective study of the total insertion period of peripherally inserted central catheter: discussion of anti-thrombogenic surface and other biomaterial requirements.
Leung TK; Chang CP; Lee CM; Shen LK
Biomed Mater Eng; 2006; 16(3):183-8. PubMed ID: 16518017
[TBL] [Abstract][Full Text] [Related]
18. Short-term complications of central line placement in children with the human immunodeficiency virus.
Island ER; Church JA; Shaul DB
J Pediatr Surg; 2001 Dec; 36(12):1777-80. PubMed ID: 11733905
[TBL] [Abstract][Full Text] [Related]
19. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
Samaras P; Dold S; Braun J; Kestenholz P; Breitenstein S; Imhof A; Renner C; Stenner-Liewen F; Pestalozzi BC
Oncology; 2008; 74(3-4):237-44. PubMed ID: 18716418
[TBL] [Abstract][Full Text] [Related]
20. Large-bore tunneled central venous catheter insertion in patients with coagulopathy.
Haas B; Chittams JL; Trerotola SO
J Vasc Interv Radiol; 2010 Feb; 21(2):212-7. PubMed ID: 20123206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
